Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Apr;23(4):725–730. doi: 10.1128/jcm.23.4.725-730.1986

Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.

J Kahlon, F D Lakeman, M Ackermann, R J Whitley
PMCID: PMC362825  PMID: 2422204

Abstract

Human antibody responses to specific polypeptides of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2, respectively) were assessed in serial serum specimens from 18 infected patients by immunoblot technology. Nine patients had HSV-1 infections (six genital and three oral) and nine had HSV-2 genital infections. Antibodies to homologous and heterologous HSV antigens were studied and correlated with total microneutralization and enzyme-linked immunosorbent assay antibodies as well as correlated directly to purified glycoproteins. The data indicated a sequential appearance of antibodies to specific polypeptides, according to virus type and site of infection. After HSV-1 infection, the initial response was to glycoprotein B, but the same was not true for HSV-2 infection, where the initial response appeared to be to the type-specific glycoprotein G. A difference in sequential appearance of antibodies for the two viruses indicated greater reactivity to lower-molecular-weight polypeptides after genital infection, irrespective of type, in contrast to nongenital HSV-1 infections. The antibody responses for selected sera to purified glycoproteins B and D were verified by enzyme-linked immunosorbent assay antibody determinations.

Full text

PDF
725

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvin A. M., Koropchak C. M., Yeager A. S., Pereira L. Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody. Infect Immun. 1983 Apr;40(1):184–189. doi: 10.1128/iai.40.1.184-189.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashley R. L., Corey L. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. J Clin Invest. 1984 Mar;73(3):681–688. doi: 10.1172/JCI111260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BUDDINGH G. J., SCHRUM D. I., LANIER J. C., GUIDRY D. J. Studies of the natural history of herpes simplex infections. Pediatrics. 1953 Jun;11(6):595–610. [PubMed] [Google Scholar]
  4. Berman P. W., Gregory T., Crase D., Lasky L. A. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science. 1985 Mar 22;227(4693):1490–1492. doi: 10.1126/science.2983428. [DOI] [PubMed] [Google Scholar]
  5. Bernstein D. I., Garratty E., Lovett M. A., Bryson Y. J. Comparison of Western Blot Analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies. J Med Virol. 1985 Mar;15(3):223–230. doi: 10.1002/jmv.1890150303. [DOI] [PubMed] [Google Scholar]
  6. Bernstein D. I., Lovett M. A., Bryson Y. J. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis. 1984 Jul;150(1):7–13. doi: 10.1093/infdis/150.1.7. [DOI] [PubMed] [Google Scholar]
  7. Coleman R. M., Pereira L., Bailey P. D., Dondero D., Wickliffe C., Nahmias A. J. Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J Clin Microbiol. 1983 Aug;18(2):287–291. doi: 10.1128/jcm.18.2.287-291.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Douglas R. G., Jr, Couch R. B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289–295. [PubMed] [Google Scholar]
  9. Eberle R., Mou S. W. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. J Infect Dis. 1983 Sep;148(3):436–444. doi: 10.1093/infdis/148.3.436. [DOI] [PubMed] [Google Scholar]
  10. Eberle R., Mou S. W., Zaia J. A. Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type 2 infections. J Gen Virol. 1984 Oct;65(Pt 10):1839–1843. doi: 10.1099/0022-1317-65-10-1839. [DOI] [PubMed] [Google Scholar]
  11. Eisenberg R. J., Ponce de Leon M., Pereira L., Long D., Cohen G. H. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol. 1982 Mar;41(3):1099–1104. doi: 10.1128/jvi.41.3.1099-1104.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Forghani B., Klassen T., Baringer J. R. Radioimmunoassay of herpes simplex virus antibody: correlation with ganglionic infection. J Gen Virol. 1977 Sep;36(3):371–375. doi: 10.1099/0022-1317-36-3-371. [DOI] [PubMed] [Google Scholar]
  13. Glorioso J. C., Smith J. W. Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol. 1977 Jan;118(1):114–121. [PubMed] [Google Scholar]
  14. Heine J. W., Spear P. G., Roizman B. Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane. J Virol. 1972 Mar;9(3):431–439. doi: 10.1128/jvi.9.3.431-439.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med. 1973 Sep 27;289(13):667–674. doi: 10.1056/NEJM197309272891305. [DOI] [PubMed] [Google Scholar]
  16. Pauls F. P., Dowdle W. R. A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol. 1967 May;98(5):941–947. [PubMed] [Google Scholar]
  17. Pereira L., Dondero D. V., Gallo D., Devlin V., Woodie J. D. Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun. 1982 Jan;35(1):363–367. doi: 10.1128/iai.35.1.363-367.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rawls W. E., Iwamoto K., Adam E., Melnick J. L. Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol. 1970 Mar;104(3):599–606. [PubMed] [Google Scholar]
  19. Roizman B., Norrild B., Chan C., Pereira L. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology. 1984 Feb;133(1):242–247. doi: 10.1016/0042-6822(84)90447-1. [DOI] [PubMed] [Google Scholar]
  20. Skinner G. R., Hartley C. H., Whitney J. E. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests. Arch Virol. 1976;50(4):323–333. doi: 10.1007/BF01317957. [DOI] [PubMed] [Google Scholar]
  21. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yoshino K., Morishima T., Aoki Y. Complement requirement of neutralizing antibodies appearing after primary and booster immunizations with herpes simplex virus. Jpn J Microbiol. 1971 Jan;15(1):53–62. doi: 10.1111/j.1348-0421.1971.tb00550.x. [DOI] [PubMed] [Google Scholar]
  23. Zweerink H. J., Corey L. Virus-specific antibodies in sera from patients with genital herpes simplex virus infection. Infect Immun. 1982 Aug;37(2):413–421. doi: 10.1128/iai.37.2.413-421.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zweerink H. J., Stanton L. W. Immune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections. Infect Immun. 1981 Feb;31(2):624–630. doi: 10.1128/iai.31.2.624-630.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES